Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NOVATION-1: A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Evaluate the Safety and Efficacy of Aerosolized Novaferon + SOC vs. Placebo + SOC in Hospitalized Adult Patients With Moderate to Severe COVID-19

NCT04669015 is registered in ClinicalTrials.gov with Genova Inc. as lead sponsor.

NCT NCT04669015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04669015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NOVATION-1: A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Evaluate the Safety and Efficacy of Aerosolized Novaferon + SOC vs. Placebo + SOC in Hospitalized Adult Patients With Moderate to Severe COVID-19
Lead sponsor
Genova Inc.
Phase
Phase 3
Overall status
Unknown status
Start date
June 10, 2021
Completion date
August 31, 2022
Enrollment
914 (estimated)
Sites
88

Conditions

As the registry lists them; a condition with its own page is linked.

covid19